TrialBMC infectious diseases2018

Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.

Carine Claeys et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.